About ATP-dependent RNA helicase DDX19B
ATP-dependent RNA helicase DDX19B (DDX19B) is a protein
from Homo sapiens identified by UniProt accession
Q9UMR2, 479 residues long.
MolForge cross-references it against 0 known binders and
97 disease associations.
Target properties
| Protein name | ATP-dependent RNA helicase DDX19B |
| UniProt accession | Q9UMR2 |
| Gene | DDX19B |
| Organism | Homo sapiens |
| Length | 479 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (97)
Diseases linked to this target (Open Targets).
- systolic blood pressure · score 0.21
- haptoglobin measurement · score 0.17
- body mass index · score 0.14
- body height · score 0.14
- amino acid measurement · score 0.09
- azoospermia · score 0.08
- urate measurement · score 0.08
- male infertility with teratozoospermia due to single gene mutation · score 0.07
- protein measurement · score 0.06
- blood metabolite measurement · score 0.06
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9UMR2-F1 | alphafold | PREDICTED | 81.53 | — |
Amino-acid sequence (479 residues)
MATDSWALAV DEQEAAAESL SNLHLKEEKI KPDTNGAVVK TNANAEKTDE EEKEDRAAQS LLNKLIRSNL VDNTNQVEVL QRDPNSPLYS VKSFEELRLK PQLLQGVYAM GFNRPSKIQE NALPLMLAEP PQNLIAQSQS GTGKTAAFVL AMLSQVEPAN KYPQCLCLSP TYELALQTGK VIEQMGKFYP ELKLAYAVRG NKLERGQKIS EQIVIGTPGT VLDWCSKLKF IDPKKIKVFV LDEADVMIAT QGHQDQSIRI QRMLPRNCQM LLFSATFEDS VWKFAQKVVP DPNVIKLKRE EETLDTIKQY YVLCSSRDEK FQALCNLYGA ITIAQAMIFC HTRKTASWLA AELSKEGHQV ALLSGEMMVE QRAAVIERFR EGKEKVLVTT NVCARGIDVE QVSVVINFDL PVDKDGNPDN ETYLHRIGRT GRFGKRGLAV NMVDSKHSMN ILNRIQEHFN KKIERLDTDD LDEIEKIAN
Explore ATP-dependent RNA helicase DDX19B with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets